New Secondary Analysis of Phase 3 Data Demonstrates Sotagliflozin Improves Time-In-Range (TIR) and Several Parameters of Glucose Control and Variability in Basal Insulin-Treated Type 2 Diabetes

1 year ago

Study results aligned with positive clinical trial outcomes for type 1 diabetes treatment with sotagliflozin   TIR measures approach target set…

Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

1 year ago

Clinical trial demonstrates the ability of nVNS to accelerate sensorimotor learning in USAF Simulator Based Pilot TrainingROCKAWAY, N.J., Sept. 10,…

American Burn Association Study Highlights Inequities in Access to Specialized Burn Care

1 year ago

Spectral AI’s DeepView® System Designed to Provide Equity in Burn Care Access While Optimizing Healthcare ResourcesDALLAS, Sept. 10, 2024 (GLOBE…

A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are

1 year ago

AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The latest report from the Access to Medicine Foundation takes a first-ever look…

Vaping Expected to Increase COPD Health and Economic Burden by 2050

1 year ago

New ResMed-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in Western Europe, accounting for…

Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024

1 year ago

SAN DIEGO, CA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma,” “Connect” or the…

Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference

1 year ago

CARLSBAD, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious…

Korro to Participate in Upcoming Investor Conferences

1 year ago

CAMBRIDGE, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing…

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024

1 year ago

SOUTH SAN FRANCISCO, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and…

ViaDerma Completes First Shipment of 500,000 Units to Nigeria

1 year ago

A second shipment of 500,000 units is expected to be made by the end of OctoberLOS ANGELES, Sept. 10, 2024…